This report focuses on the global Preimplantation Genetic Diagnostics (PGD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Preimplantation Genetic Diagnostics (PGD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Illumina, Inc. Thermo Fisher Scientific Inc. Agilent Technologies, Inc. Perkinelmer, Inc. Cooper Surgical ABBott Laboratories Natera, Inc. Rubicon Genomics Oxford Gene Technology Yikon Genomics Scigene Beijing Genomics Institute (BGI) Genea Limited Hamilton Thorne FUJIFILM Irvine Scientific Nidacon International Vitrolife AB Merck INVO Bioscience IVFtech Gonagen Medikal Cook Medical CellCura Market segment by Type, the product can be split into Preimplantation Genetic Screening Preimplantation Genetic Diagnosis Market segment by Application, split into Fertility Clinics Academic Medical Centers Others Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Preimplantation Genetic Diagnostics (PGD) status, future forecast, growth opportunity, key market and key players. To present the Preimplantation Genetic Diagnostics (PGD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions. In this study, the years considered to estimate the market size of Preimplantation Genetic Diagnostics (PGD) are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Market Estimation
Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.
Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Preimplantation Genetic Diagnostics (PGD) Revenue 1.4 Covid-19 Implications on Market by Type 1.4.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Preimplantation Genetic Screening 1.4.3 Preimplantation Genetic Diagnosis 1.5 Covid-19 Implications on Market by Application 1.5.1 Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application: 2020 VS 2026 1.5.2 Fertility Clinics 1.5.3 Academic Medical Centers 1.5.4 Others 1.6 Coronavirus Disease 2019 (Covid-19): Preimplantation Genetic Diagnostics (PGD) Industry Impact 1.6.1 How the Covid-19 is Affecting the Preimplantation Genetic Diagnostics (PGD) Industry 1.6.1.1 Preimplantation Genetic Diagnostics (PGD) Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19?s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Preimplantation Genetic Diagnostics (PGD) Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Preimplantation Genetic Diagnostics (PGD) Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Covid-19 Implications on Global Preimplantation Genetic Diagnostics (PGD) Market Perspective (2015-2026) 2.2 Covid-19 Implications on Global Preimplantation Genetic Diagnostics (PGD) Growth Trends by Regions 2.2.1 Preimplantation Genetic Diagnostics (PGD) Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Preimplantation Genetic Diagnostics (PGD) Historic Market Share by Regions (2015-2020) 2.2.3 Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter?s Five Forces Analysis 2.3.5 Preimplantation Genetic Diagnostics (PGD) Market Growth Strategy 2.3.6 Primary Interviews with Key Preimplantation Genetic Diagnostics (PGD) Players (Opinion Leaders) 3 Covid-19 Implications on Competition Landscape by Key Players 3.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Market Size 3.1.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Revenue (2015-2020) 3.1.2 Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Players (2015-2020) 3.1.3 Global Preimplantation Genetic Diagnostics (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio 3.2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Diagnostics (PGD) Revenue in 2019 3.3 Preimplantation Genetic Diagnostics (PGD) Key Players Head office and Area Served 3.4 Key Players Preimplantation Genetic Diagnostics (PGD) Product Solution and Service 3.5 Date of Enter into Preimplantation Genetic Diagnostics (PGD) Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Covid-19 Implications on Market Size by Type (2015-2026) 4.1 Global Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Type (2015-2020) 4.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Type (2021-2026) 5 Covid-19 Implications on Market Size by Application (2015-2026) 5.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) 5.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020) 6.2 Preimplantation Genetic Diagnostics (PGD) Key Players in North America (2019-2020) 6.3 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) 6.4 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) 7 Europe 7.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020) 7.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Europe (2019-2020) 7.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) 7.4 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) 8 China 8.1 China Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020) 8.2 Preimplantation Genetic Diagnostics (PGD) Key Players in China (2019-2020) 8.3 China Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) 8.4 China Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) 9 Japan 9.1 Japan Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020) 9.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Japan (2019-2020) 9.3 Japan Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) 9.4 Japan Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020) 10.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) 10.4 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) 11 India 11.1 India Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020) 11.2 Preimplantation Genetic Diagnostics (PGD) Key Players in India (2019-2020) 11.3 India Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) 11.4 India Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020) 12.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Central & South America (2019-2020) 12.3 Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) 12.4 Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Illumina, Inc. 13.1.1 Illumina, Inc. Company Details 13.1.2 Illumina, Inc. Business Overview and Its Total Revenue 13.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction 13.1.4 Illumina, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)) 13.1.5 Illumina, Inc. Recent Development 13.2 Thermo Fisher Scientific Inc. 13.2.1 Thermo Fisher Scientific Inc. Company Details 13.2.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue 13.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Introduction 13.2.4 Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 13.2.5 Thermo Fisher Scientific Inc. Recent Development 13.3 Agilent Technologies, Inc. 13.3.1 Agilent Technologies, Inc. Company Details 13.3.2 Agilent Technologies, Inc. Business Overview and Its Total Revenue 13.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction 13.3.4 Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 13.3.5 Agilent Technologies, Inc. Recent Development 13.4 Perkinelmer, Inc. 13.4.1 Perkinelmer, Inc. Company Details 13.4.2 Perkinelmer, Inc. Business Overview and Its Total Revenue 13.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction 13.4.4 Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 13.4.5 Perkinelmer, Inc. Recent Development 13.5 Cooper Surgical 13.5.1 Cooper Surgical Company Details 13.5.2 Cooper Surgical Business Overview and Its Total Revenue 13.5.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Introduction 13.5.4 Cooper Surgical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 13.5.5 Cooper Surgical Recent Development 13.6 ABBott Laboratories 13.6.1 ABBott Laboratories Company Details 13.6.2 ABBott Laboratories Business Overview and Its Total Revenue 13.6.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Introduction 13.6.4 ABBott Laboratories Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 13.6.5 ABBott Laboratories Recent Development 13.7 Natera, Inc. 13.7.1 Natera, Inc. Company Details 13.7.2 Natera, Inc. Business Overview and Its Total Revenue 13.7.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction 13.7.4 Natera, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 13.7.5 Natera, Inc. Recent Development 13.8 Rubicon Genomics 13.8.1 Rubicon Genomics Company Details 13.8.2 Rubicon Genomics Business Overview and Its Total Revenue 13.8.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction 13.8.4 Rubicon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 13.8.5 Rubicon Genomics Recent Development 13.9 Oxford Gene Technology 13.9.1 Oxford Gene Technology Company Details 13.9.2 Oxford Gene Technology Business Overview and Its Total Revenue 13.9.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Introduction 13.9.4 Oxford Gene Technology Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 13.9.5 Oxford Gene Technology Recent Development 13.10 Yikon Genomics 13.10.1 Yikon Genomics Company Details 13.10.2 Yikon Genomics Business Overview and Its Total Revenue 13.10.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction 13.10.4 Yikon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 13.10.5 Yikon Genomics Recent Development 13.11 Scigene 10.11.1 Scigene Company Details 10.11.2 Scigene Business Overview and Its Total Revenue 10.11.3 Scigene Preimplantation Genetic Diagnostics (PGD) Introduction 10.11.4 Scigene Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 10.11.5 Scigene Recent Development 13.12 Beijing Genomics Institute (BGI) 10.12.1 Beijing Genomics Institute (BGI) Company Details 10.12.2 Beijing Genomics Institute (BGI) Business Overview and Its Total Revenue 10.12.3 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Introduction 10.12.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 10.12.5 Beijing Genomics Institute (BGI) Recent Development 13.13 Genea Limited 10.13.1 Genea Limited Company Details 10.13.2 Genea Limited Business Overview and Its Total Revenue 10.13.3 Genea Limited Preimplantation Genetic Diagnostics (PGD) Introduction 10.13.4 Genea Limited Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 10.13.5 Genea Limited Recent Development 13.14 Hamilton Thorne 10.14.1 Hamilton Thorne Company Details 10.14.2 Hamilton Thorne Business Overview and Its Total Revenue 10.14.3 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Introduction 10.14.4 Hamilton Thorne Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 10.14.5 Hamilton Thorne Recent Development 13.15 FUJIFILM Irvine Scientific 10.15.1 FUJIFILM Irvine Scientific Company Details 10.15.2 FUJIFILM Irvine Scientific Business Overview and Its Total Revenue 10.15.3 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Introduction 10.15.4 FUJIFILM Irvine Scientific Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 10.15.5 FUJIFILM Irvine Scientific Recent Development 13.16 Nidacon International 10.16.1 Nidacon International Company Details 10.16.2 Nidacon International Business Overview and Its Total Revenue 10.16.3 Nidacon International Preimplantation Genetic Diagnostics (PGD) Introduction 10.16.4 Nidacon International Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 10.16.5 Nidacon International Recent Development 13.17 Vitrolife AB 10.17.1 Vitrolife AB Company Details 10.17.2 Vitrolife AB Business Overview and Its Total Revenue 10.17.3 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Introduction 10.17.4 Vitrolife AB Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 10.17.5 Vitrolife AB Recent Development 13.18 Merck 10.18.1 Merck Company Details 10.18.2 Merck Business Overview and Its Total Revenue 10.18.3 Merck Preimplantation Genetic Diagnostics (PGD) Introduction 10.18.4 Merck Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 10.18.5 Merck Recent Development 13.19 INVO Bioscience 10.19.1 INVO Bioscience Company Details 10.19.2 INVO Bioscience Business Overview and Its Total Revenue 10.19.3 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Introduction 10.19.4 INVO Bioscience Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 10.19.5 INVO Bioscience Recent Development 13.20 IVFtech 10.20.1 IVFtech Company Details 10.20.2 IVFtech Business Overview and Its Total Revenue 10.20.3 IVFtech Preimplantation Genetic Diagnostics (PGD) Introduction 10.20.4 IVFtech Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 10.20.5 IVFtech Recent Development 13.21 Gonagen Medikal 10.21.1 Gonagen Medikal Company Details 10.21.2 Gonagen Medikal Business Overview and Its Total Revenue 10.21.3 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Introduction 10.21.4 Gonagen Medikal Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 10.21.5 Gonagen Medikal Recent Development 13.22 Cook Medical 10.22.1 Cook Medical Company Details 10.22.2 Cook Medical Business Overview and Its Total Revenue 10.22.3 Cook Medical Preimplantation Genetic Diagnostics (PGD) Introduction 10.22.4 Cook Medical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 10.22.5 Cook Medical Recent Development 13.23 CellCura 10.23.1 CellCura Company Details 10.23.2 CellCura Business Overview and Its Total Revenue 10.23.3 CellCura Preimplantation Genetic Diagnostics (PGD) Introduction 10.23.4 CellCura Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) 10.23.5 CellCura Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details
